Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant ...

Request To Download Free Sample of This Strategic Report @- In addition, continuous effort in R&D activities for drug discovery, development & screening and inclination toward the use of 3D cell ...

The global biobanking market was valued at $37.93 billion in 2019, and is estimated to reach $57.67 billion by 2027, growing at a CAGR of 4.6% from 2020 to 2027. Rise in funding b ...

Well, in Dimension’s case, they end up investing in some buzzy AI startups, counseling pharmaceutical companies, ribbing one ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced longer-term data for CASGEVY™ (exagamglogene autotemcel) from global clinical trial ...